Maturitas
Volume 65, Issue 3 , Pages 262-266, March 2010

Menopause is an independent predictor of metabolic syndrome in Iranian women

  • Radina Eshtiaghi

      Affiliations

    • AJA University of Medical Science, 3th Floor, Endocrine Research Center, Emam Reza Hospital (501-AJA), Etemad Zadeh Ave, Fatemi St, Tehran, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 21 88630376; fax: +98 21 88028724.
  • ,
  • Alireza Esteghamati

      Affiliations

    • Endocrinology & Metabolism Research Center, Tehran University of Medical Science, Tehran, Iran
  • ,
  • Manouchehr Nakhjavani

      Affiliations

    • Endocrinology & Metabolism Research Center, Tehran University of Medical Science, Tehran, Iran

Received 4 September 2009; received in revised form 29 October 2009; accepted 2 November 2009. published online 20 November 2009.

Abstract 

Background

Gender differences in prevalence and consequences of the metabolic syndrome as a strong predictor of cardiovascular disease (CVD), are challenging problems. Postmenopausal status may explain in part the cause of acceleration of CVD with aging. The purpose of this study was to investigate the relation of menopause and metabolic syndrome independent of aging among Iranian women.

Methods

On the basis of consecutive recruitment, 940 women between 20 and 76 years old participated in the study. Anthropometric indices, fasting blood glucose, lipid profile were measured, Framingham risk score and homeostasis model assessment (HOMA-IR) were calculated for all participants. The metabolic syndrome (MetS) was defined according to the National Cholesterol Education Program Adult Treatment Panel III. We used IDF definition for metabolic syndrome modified by our recent local data as an alternative measurements.

Results

The overall prevalence of metabolic syndrome was 26.4%. Its prevalence was 53.5% in postmenopausal versus 18.3% in premenopausal women. On binary logistic regression analysis, HOMA index, body mass index, waist to hip ratio, family history of diabetes and hypertension had an independent and significant effect on metabolic syndrome. Age-adjusted odds ratio (OR) of postmenopausal status for metabolic syndrome was 2.85 (95%CI: 1.31–6.20) (P<0.008). Framingham risk score was 8.3±7.7 in MetS+ve cases versus 1.9±2.1 in MetS−ve cases (P<0.001). There were significant differences between Framingham risk score in postmenopause 9.1±6.4 versus premenopause 1.6±1.6 (P<0.001). A significant correlation was found between Framingham risk score and body mass index, waist to hip ratio, HOMA-IR and components of metabolic syndrome (P<0.001). Forty percent of participants with premature menopause had metabolic syndrome versus 24% in age-matched group and Framingham risk score was significantly higher than normal cases 5.4±4.9 versus 2.0±2.3 (P<0.001).

Conclusion

Menopausal status can be a predictor of metabolic syndrome independent of age in Iranian women. Menopause is a process closely related to insulin resistance and cardiovascular risk factors.

Keywords: Metabolic syndrome, Menopause, HOMA index, Framingham risk score, Gender difference

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(09)00403-4

doi:10.1016/j.maturitas.2009.11.004

Maturitas
Volume 65, Issue 3 , Pages 262-266, March 2010